SCHEMBL13667703

SCHEMBL13667703

COc1cc2c(Cc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCOCC1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 17/20 0.79
▸ EGFR P00533 3/20 0.68
▸ MET P08581 3/20 0.68
▸ SRC P12931 3/20 0.68
▸ PLK4 O00444 1/20 0.68
▸ AURKA O14965 1/20 0.68
▸ GAK O14976 1/20 0.68
▸ RIPK2 O43353 1/20 0.68
▸ PRKAB2 O43741 1/20 0.68
▸ ERN1 O75460 1/20 0.68
▸ STK10 O94804 1/20 0.68
▸ MAP4K4 O95819 1/20 0.68
▸ FYN P06241 1/20 0.68
▸ YES1 P07947 1/20 0.68
▸ LYN P07948 1/20 0.68
▸ FER P16591 1/20 0.68
▸ MARK3 P27448 1/20 0.68
▸ MAP2K2 P36507 1/20 0.68
▸ TGFBR2 P37173 1/20 0.68
▸ CSK P41240 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13667704 0.92 AXL (0.68) AXLEGFRMETSRCPLK4
SCHEMBL13667556 0.90 AXL (0.70) AXLEGFRMETSRCPLK4
SCHEMBL13667535 0.89 AXL (0.66) AXLEGFRMETSRCKIT
SCHEMBL1591147 0.88 AXL (1.00) AXLEGFRMETSRCPLK4
SCHEMBL10328536 0.88 AXL (0.64) AXLEGFRMETSRCKIT
SCHEMBL10328541 0.88 AXL (0.64) AXLEGFRMETSRCKIT
SCHEMBL1546564 0.86 AXL (1.00) AXLEGFRMETSRCPLK4
SCHEMBL13667526 0.85 AXL (0.62) AXLEGFRMETSRCPLK4
SCHEMBL1546615 0.84 AXL (1.00) AXLEGFRMETSRCPLK4
SCHEMBL13667553 0.83 AXL (0.64) AXLEGFRMETSRCPLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009127417-A1 QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2009-10-22 — — WO disclosed
Send feedback